These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37247404)

  • 21. Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial.
    Mortsiefer A; Löscher S; Pashutina Y; Santos S; Altiner A; Drewelow E; Ritzke M; Wollny A; Thürmann P; Bencheva V; Gogolin M; Meyer G; Abraham J; Fleischer S; Icks A; Montalbo J; Wiese B; Wilm S; Feldmeier G
    JAMA Netw Open; 2023 Mar; 6(3):e234723. PubMed ID: 36972052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial.
    Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Mixon AS; Bell SP; Kripalani S; Schnelle JF; Simmons SF;
    BMC Health Serv Res; 2019 Mar; 19(1):165. PubMed ID: 30871561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care - A cluster-randomised clinical trial.
    Zechmann S; Senn O; Valeri F; Essig S; Merlo C; Rosemann T; Neuner-Jehle S
    BMC Geriatr; 2020 Nov; 20(1):471. PubMed ID: 33198634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.
    Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A;
    Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial.
    Sheppard JP; Burt J; Lown M; Temple E; Benson J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Little P; Mant J; Mollison J; Nickless A; Ogburn E; Payne R; Williams M; Yu LM; McManus RJ
    BMJ Open; 2018 Oct; 8(9):e022930. PubMed ID: 30287610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decision-Making Preferences and Deprescribing: Perspectives of Older Adults and Companions About Their Medicines.
    Weir K; Nickel B; Naganathan V; Bonner C; McCaffery K; Carter SM; McLachlan A; Jansen J
    J Gerontol B Psychol Sci Soc Sci; 2018 Sep; 73(7):e98-e107. PubMed ID: 29190369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
    Balsom C; Pittman N; King R; Kelly D
    Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care.
    McDonald EG; Wu PE; Rashidi B; Forster AJ; Huang A; Pilote L; Papillon-Ferland L; Bonnici A; Tamblyn R; Whitty R; Porter S; Battu K; Downar J; Lee TC
    J Am Geriatr Soc; 2019 Sep; 67(9):1843-1850. PubMed ID: 31250427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital admission as a deprescribing triage point for patients discharged to Residential Aged Care Facilities.
    Roberts G; Pegoli M; Grzeskowiak L; Benger S; Forbes H; Hunt K; Jafari S; Koeper I; McDonald C; Nguyen H; Rawther K; Taeuber L; Tran E; Vu P; Wisdom A; Russell P
    Age Ageing; 2021 Sep; 50(5):1600-1606. PubMed ID: 34036308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidisciplinary Team Deprescribing Intervention for Polypharmacy in Elderly Orthopedic Inpatients: A Propensity Score-matched Analysis of a Retrospective Cohort Study.
    Seto H; Ishimaru N; Ohnishi J; Kanzawa Y; Nakajima T; Shimokawa T; Imanaka Y; Kinami S
    Intern Med; 2022 Aug; 61(16):2417-2426. PubMed ID: 35022357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
    Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
    J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.
    Qi K; Reeve E; Hilmer SN; Pearson SA; Matthews S; Gnjidic D
    Int J Clin Pharm; 2015 Oct; 37(5):949-57. PubMed ID: 26047944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
    Komagamine J; Sugawara K; Hagane K
    BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attitudes toward deprescribing among adults with heart failure with preserved ejection fraction.
    Navid P; Nguyen L; Jaber D; Zarzuela K; Musse M; Lu Wang M; Requijo T; Kozlov E; Masterson Creber RM; Hilmer SN; Lachs M; Goyal P
    J Am Geriatr Soc; 2021 Jul; 69(7):1948-1955. PubMed ID: 33978239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-designing an intervention to improve the process of deprescribing for older people living with frailty in the United Kingdom.
    Silcock J; Marques I; Olaniyan J; Raynor DK; Baxter H; Gray N; Zaidi STR; Peat G; Fylan B; Breen L; Benn J; Alldred DP
    Health Expect; 2023 Feb; 26(1):399-408. PubMed ID: 36420768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
    Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
    Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol.
    Simões PA; Santiago LM; Simões JA
    BMJ Open; 2018 Jul; 8(7):e019542. PubMed ID: 30018092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.